Biocartis Group NV (CHIX:BCARTB) Operating Cash Flow per Share : €-0.64 (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Biocartis Group NV Operating Cash Flow per Share?

Biocartis Group NV's operating cash flow per share for the six months ended in Jun. 2023 was €-0.31. Biocartis Group NV's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.64.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Biocartis Group NV's Operating Cash Flow per Share or its related term are showing as below:

CHIX:BCARTb's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 3.35
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Biocartis Group NV Operating Cash Flow per Share Historical Data

The historical data trend for Biocartis Group NV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocartis Group NV Operating Cash Flow per Share Chart

Biocartis Group NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.70

-0.83

-0.59

-1.14

-0.74

Biocartis Group NV Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.50	-0.67	-0.42	-0.33	-0.31

Competitive Comparison of Biocartis Group NV's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Biocartis Group NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocartis Group NV's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Biocartis Group NV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Biocartis Group NV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-44.855	/	60.546
	=	-0.74

Biocartis Group NV's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-29.262	/	93.231
	=	-0.31

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.64

Biocartis Group NV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Biocartis Group NV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocartis Group NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (CHIX:BCARTb) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Generaal de Wittelaan 11 B, Mechelen, BEL, 2800

Website

https://www.biocartis.com

Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV Headlines

No Headlines